Antihistamine shown to improve function in MS patients

Oct. 11 (UPI) -- A Phase II clinical trial showed that an antihistamine can restore nervous system function in patients with chronic multiple sclerosis.
Researchers from the University of California, San Francisco, completed the clinical trial of the U.S. Food and Drug Administration-approved antihistamine clemastine fumarate on patients with MS.
Read more..
cool medical gadgets, new medical devices, medical device technology scientific poster